| AFs | Actin filaments |
| ABD | Actin-binding domain |
| AML | Acute myeloid leukemia |
| ALDH | Aldehyde dehydrogenase |
| BCC | Basal cell carcinomas |
| CSCs | Cancer stem cells |
| CSP | Cancer-specific plectin |
| CRC | Colorectal cancer |
| ECM | Extracellular matrix |
| EGFR | Epidermal growth factor receptor |
| EMT | Epithelial–mesenchymal transition |
| Erk 1/2 | Extracellular signal-regulated kinase 1/2 |
| ESCC | Esophageal squamous cell carcinoma |
| FAs | Focal adhesions |
| FAK | Focal adhesion kinase |
| GBM | Glioblastoma multiforme |
| HNSCC | Head and neck squamous cell carcinoma |
| HDs | Hemidesmosomes |
| HCC | Hepatocellular carcinoma |
| IFs | Intermediate filaments |
| OSCC | Oral squamous cell carcinoma |
| PDAC | Pancreatic ductal adenocarcinoma |
| PanINs | Pancreatic intraepithelial neoplasms |
| PST | Plecstatin-1 |
| SCC | Squamous cell carcinomas |
| Src | Rous sarcoma |
| SSE | Stratified squamous epithelium |
| Rac1 | Ras-related C3 botulinum toxin substrate 1 |
| TME | Tumor microenvironment |